Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011		Dec. 31, 2010
OPERATING ACTIVITIES:
Net income (loss)	$ 27,680	$ (449,884)		$ 52,681
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	26,580	30,140		22,576
Amortization and write-off of debt issuance costs	13,761	16,263		5,016
Provision for doubtful accounts	4,066	8,541		10,285
Equity-based compensation expense	7,645	7,548		6,279
Windfall tax benefits associated with equity-based compensation	(88)	(192)		(948)
Goodwill, intangibles and other long-lived asset impairment	19,132	643,305	[1]	0
(Gain) loss on sale of assets and businesses, net	(8,014)	(12,536)		2,031
Equity in net (loss) earnings of CareCentrix, including gain on sale, net of tax	2,301	(68,381)		(1,298)
Deferred income tax expense (benefit)	23,513	(86,012)		(1,220)
Changes in assets and liabilities, net of effects from acquisitions and dispositions:
Accounts receivable	34,882	(39,542)		35,600
Prepaid expenses and other current assets	(15,447)	10,467		(16,000)
Accounts payable	832	(2,949)		6,590
Payroll and related taxes	3,275	(2,136)		(4,139)
Deferred revenue	3,330	(2,273)		28
Medicare liabilities	4,142	(8,170)		11,250
Obligations under insurance programs	1,560	(6,923)		4,549
Accrued nursing home costs	(5,795)	(18)		7,549
Other accrued expenses	(23,323)	(31,642)		(275)
Other, net	5,936	(465)		2,067
Net cash provided by operating activities	125,968	5,141		142,621
INVESTING ACTIVITIES:
Purchase of fixed assets	(11,779)	(19,231)		(16,184)
Proceeds from sale of businesses, net of cash transferred	9,220	146,315		9,796
Acquisition of businesses, net of cash acquired	(22,335)	(320)		(834,919)
Net cash (used in) provided by investing activities	(24,894)	126,764		(841,307)
FINANCING ACTIVITIES:
Proceeds from issuance of common stock	3,980	7,901		8,618
Windfall tax benefits associated with equity-based compensation	88	192		948
Proceeds from issuance of debt	0	0		1,075,000
Borrowings under revolving credit facility	0	0		30,000
Repayment of borrowings under revolving credit facility	0	0		(30,000)
Repayment of long-term debt	(52,943)	(63,438)		(260,437)
Repayment of Odyssey debt	0	0		(108,822)
Repurchase of common stock	(4,974)	0		(4,985)
Debt issuance costs	(4,125)	(15,460)		(58,577)
Repayment of capital lease obligations	(135)	(267)		(645)
Other	(825)	(673)		(72)
Net cash (used in) provided by financing activities	(58,934)	(71,745)		651,028
Net change in cash and cash equivalents	42,140	60,160		(47,658)
Cash and cash equivalents at beginning of period	164,912	104,752		152,410
Cash and cash equivalents at end of period	207,052	164,912		104,752
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Interest paid	78,783	78,639		24,052
Income taxes paid	$ 4,375	$ 38,067		$ 47,446

[1] For the year ended December 31, 2012, the Company recorded non-cash impairment charges associated with a write-off of its trade name intangibles of $19.1 million in connection with the Company's initiative to re-brand its operations under the Gentiva name. Home Health and Hospice assets were reduced by $6.0 million and $13.1 million, respectively, as of December 31, 2012 as a result of the impairment.For the year ended December 31, 2011, the Company recorded non-cash impairment charges associated with goodwill, intangibles and other long-lived assets of $643.3 million. This charge was the result of (i) changes in the Company's business climate, (ii) uncertainties around Medicare reimbursement as the federal government worked to reduce the federal deficit, (iii) a significant decline in the price of the Company's common stock during the fiscal year, (iv) a write-down of software and (v) a change in the estimated fair value of real estate. Home Health, Hospice and corporate assets were reduced by $408.4 million, $193.7 million and $41.2 million, respectively, as of December 31, 2011, as a result of the impairment.